Glucagon-like peptide-1 receptor agonist use and clinical outcomes after lung transplantation: A single-center cohort study

Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are increasingly used for diabetes and obesity, but their safety and clinical impact after lung transplantation (LTx) are unclear. Methods: We performed a single-center retrospective cohort study of adults undergoing primary LTx from 2...

Cijeli opis

Bibliografski detalji

Glavni autori:	Yudai Miyashita, MD, Taisuke Kaiho, MD, Rachel Reichenbach, MD, Yuriko Yagi, MD, Ambalavan Arunachalam, MD, Chitaru Kurihara, MD
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2026-05-01
Serija:	JHLT Open
Teme:	Lung transplantation Glucagon-like peptide-1 receptor agonist Primary graft dysfunction Chronic lung allograft dysfunction Survival
Online pristup:	http://www.sciencedirect.com/science/article/pii/S2950133426000340
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!